Please use this identifier to cite or link to this item:
https://hdl.handle.net/20.500.14365/5234
Title: | Resting state electroencephalographic alpha rhythms are sensitive to Alzheimer's disease mild cognitive impairment progression at a 6-month follow-up | Authors: | Babiloni, C. Jakhar, D. Tucci, F. Del, Percio, C. Lopez, S. Soricelli, A. Salvatore, M. Yener, Görsev |
Keywords: | Alzheimer's disease progression Exact Low-resolution Brain Electromagnetic Source Tomography (eLORETA) Mild cognitive impairment due to Alzheimer's disease (ADMCI) Resting state electroencephalographic (rsEEG) rhythms biological marker biological marker aged alpha rhythm Alzheimer disease arousal Article controlled study disease exacerbation electroencephalogram female follow up human major clinical study male mild cognitive impairment neuroimaging resting state network wakefulness alpha rhythm brain cortex cognitive defect diagnostic imaging electroencephalography procedures psychology rest Alpha Rhythm Alzheimer Disease Biomarkers Cerebral Cortex Cognitive Dysfunction Electroencephalography Follow-Up Studies Humans Rest |
Publisher: | Elsevier Inc. | Abstract: | Are posterior resting-state electroencephalographic (rsEEG) alpha rhythms sensitive to the Alzheimer's disease mild cognitive impairment (ADMCI) progression at a 6-month follow-up? Clinical, cerebrospinal, neuroimaging, and rsEEG datasets in 52 ADMCI and 60 Healthy old seniors (equivalent groups for demographic features) were available from an international archive (www.pdwaves.eu). The ADMCI patients were arbitrarily divided into two groups: REACTIVE and UNREACTIVE, based on the reduction (reactivity) in the posterior rsEEG alpha eLORETA source activities from the eyes-closed to eyes-open condition at ≥ −10% and −10%, respectively. 75% of the ADMCI patients were REACTIVE. Compared to the UNREACTIVE group, the REACTIVE group showed (1) less abnormal posterior rsEEG source activity during the eyes-closed condition and (2) a decrease in that activity at the 6-month follow-up. These effects could not be explained by neuroimaging and neuropsychological biomarkers of AD. Such a biomarker might reflect abnormalities in cortical arousal in quiet wakefulness to be used for clinical studies in ADMCI patients using 6-month follow-ups. © 2024 The Authors | URI: | https://doi.org/10.1016/j.neurobiolaging.2024.01.013 https://hdl.handle.net/20.500.14365/5234 |
ISSN: | 0197-4580 |
Appears in Collections: | PubMed İndeksli Yayınlar Koleksiyonu / PubMed Indexed Publications Collection Scopus İndeksli Yayınlar Koleksiyonu / Scopus Indexed Publications Collection WoS İndeksli Yayınlar Koleksiyonu / WoS Indexed Publications Collection |
Show full item record
CORE Recommender
SCOPUSTM
Citations
4
checked on Nov 20, 2024
WEB OF SCIENCETM
Citations
3
checked on Nov 20, 2024
Page view(s)
72
checked on Nov 18, 2024
Download(s)
46
checked on Nov 18, 2024
Google ScholarTM
Check
Altmetric
Items in GCRIS Repository are protected by copyright, with all rights reserved, unless otherwise indicated.